KISHBAUCH MICHAEL D 4
4 · CATABASIS PHARMACEUTICALS INC · Filed Jun 5, 2019
Insider Transaction Report
Form 4
KISHBAUCH MICHAEL D
Director
Transactions
- Award
Stock Option (right to buy)
2019-06-04+7,500→ 7,500 totalExercise: $6.53Exp: 2029-06-03→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]This option was granted on June 4, 2019 and is scheduled to vest in full on June 4, 2020.